Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
10/10/2000 | CA2126648C Liposomes containing bioavailable iron (ii) and method for obtaining them |
10/10/2000 | CA2028893C Morpholinols, their prepation and use |
10/10/2000 | CA1341114C Pharmaceutical formulations containing melphalan hydrochloride |
10/08/2000 | CA2303752A1 Renal cell carcinoma treatment |
10/05/2000 | WO2000058391A1 Method of modifying surface layer of molded resin and apparatus for modifying surface layer of molded resin |
10/05/2000 | WO2000058359A1 Retro-inverso prosaposin-derived peptides and use thereof |
10/05/2000 | WO2000058308A1 DERIVATIVES OF PYRIMIDO[6,1-a]ISOQUINOLIN-4-ONE |
10/05/2000 | WO2000057919A2 Lipid-based artificial particles inducing cell-mediated immunity |
10/05/2000 | WO2000057918A2 Novel formulations comprising lipid-regulating agents |
10/05/2000 | WO2000057917A2 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
10/05/2000 | WO2000057906A1 Human papillomavirus vaccine with disassembled and reassembled virus-like particles |
10/05/2000 | WO2000057896A1 Modulators of polysaccharides and uses thereof |
10/05/2000 | WO2000057890A1 Pulmonary delivery of protonated/acidified nucleic acids |
10/05/2000 | WO2000057886A1 Dispersible macrolide compounds and method for the production thereof |
10/05/2000 | WO2000057885A1 Pharmaceutical emulsions for retroviral protease inhibitors |
10/05/2000 | WO2000057884A1 Medicinal preparation containing at least in part acetylsalicylic acid as active ingredient |
10/05/2000 | WO2000057881A1 Cilostazol preparation |
10/05/2000 | WO2000057878A1 Thiadiazolyl urea or thiourea derivatives for antiviral treatment |
10/05/2000 | WO2000057875A1 Compositions containing tea catechins as cancer specific proliferation inhibitors |
10/05/2000 | WO2000057873A2 Granulate with high content of l-carnitine or an alkanoyl l-carnitine |
10/05/2000 | WO2000057870A2 Viral treatment |
10/05/2000 | WO2000057869A2 Viral treatment |
10/05/2000 | WO2000057866A2 Use of azalide antibiotics for the topical treatment or prevention of ocular infections |
10/05/2000 | WO2000057859A1 Novel formulations comprising lipid-regulating agents |
10/05/2000 | WO2000057858A1 Sublingual buccal effervescent |
10/05/2000 | WO2000057857A1 Rapidly disintegrable tablet for oral administration |
10/05/2000 | WO2000057856A1 Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic and use and method for obtaining same |
10/05/2000 | WO2000057855A1 Solubilizing aids in powder form for solid pharmaceutical presentation forms |
10/05/2000 | WO2000057854A2 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances |
10/05/2000 | WO2000057853A2 Pharmaceutical composition containing an extrusion additive |
10/05/2000 | WO2000057852A2 Methods and compositions for treating solid tumors |
10/05/2000 | WO2000057851A2 High potency dihydroergotamine compositions |
10/05/2000 | WO2000057838A2 Coating system |
10/05/2000 | WO2000057824A1 Transdermal therapeutic system with nicotine and addition of monoterpene ketones |
10/05/2000 | WO2000057699A1 Oral anti-odor compositions |
10/05/2000 | WO2000040217B1 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
10/05/2000 | WO2000032171A3 Autoahesive oral transmucosal delivery dosage form |
10/05/2000 | WO2000025602A3 Use of calcareous material for foodstuff and cosmetic material |
10/05/2000 | WO1999055743A9 Polyanionic polymers which enhance fusogenicity |
10/05/2000 | WO1999032135A8 Keratinocyte growth factor-2 formulations |
10/05/2000 | DE19916384A1 Microparticles useful in treatment of androgen-dependent disorders include biodegradable, synthetic polymers of e.g. polyesters of hydroxycarboxylic acids |
10/05/2000 | DE19916383A1 Pharmazeutische Zusammensetzung mit einem Extrusionsstoff A pharmaceutical composition comprising an extrusion material |
10/05/2000 | DE19914621A1 Stable aqueous solution of the thalidomide derivative EM 12 for parenteral administration in isotonic glucose solution has a specified pH, useful for treating immunological, hematologic and oncologic diseases |
10/05/2000 | DE10004860A1 Pressurized air inhaler for administering drug-containing liposomal powder aerosol for treatment of respiratory disease, has nebulization chamber for drying aqueous liposome suspension |
10/05/2000 | CA2368880A1 Dispersible macrolide compounds and method for the production thereof |
10/05/2000 | CA2368651A1 Fast-dissolving isotropic expanded microporous composition or structure for pharmaceutical, veterinary, dietetic, food or cosmetic and use and method for obtaining same |
10/05/2000 | CA2368587A1 High potency dihydroergotamine compositions |
10/05/2000 | CA2367995A1 Novel formulations comprising lipid-regulating agents |
10/05/2000 | CA2367766A1 Retro-inverso prosaposin-derived peptides and use thereof |
10/05/2000 | CA2367669A1 Coating system |
10/05/2000 | CA2366604A1 Modulators of polysaccharides and uses thereof |
10/05/2000 | CA2365128A1 Novel formulations comprising lipid-regulating agents |
10/05/2000 | CA2291286A1 Chitosan-containing soft capsule and process for producing the same |
10/04/2000 | EP1041149A2 Vaccine and antitoxin for treatment and prevention of C. difficile disease |
10/04/2000 | EP1041116A2 Compositions comprising hydroxy-functional polymers |
10/04/2000 | EP1040838A1 Stable aqueous EM 12 solution |
10/04/2000 | EP1040837A2 Medicaments for the treatment of a choroidal neovascularization (CNV) related disorder |
10/04/2000 | EP1040832A1 Creams containing vitamin d 3? derivatives |
10/04/2000 | EP1040828A1 Water-base liquid preparation |
10/04/2000 | EP1040825A1 Means for diagnosing bladder carcinoma |
10/04/2000 | EP1040824A2 First aid adhesive plaster |
10/04/2000 | EP1040823A2 Stable foam compositions |
10/04/2000 | EP1040822A1 Extensible Mask with an adhesive matrix which is at least stretchable when wetted |
10/04/2000 | EP1040814A1 Nail enamel containing an aqueous polymer dispersion |
10/04/2000 | EP1039937A2 Novel sterilization process for pharmaceutical suspensions |
10/04/2000 | EP1039932A1 Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions |
10/04/2000 | EP1039928A1 Intranasal yellow fever vaccination |
10/04/2000 | EP1039920A1 Fatty acid-acylated insulin analogs |
10/04/2000 | EP1039919A1 Composition for improving mental capabilities in mammals |
10/04/2000 | EP1039917A1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
10/04/2000 | EP1039913A1 Progesterone tablet and preparation method |
10/04/2000 | EP1039909A1 Method and composition of an oral preparation of itraconazole |
10/04/2000 | EP1039908A1 Molecular dispersion composition with enhanced bioavailability |
10/04/2000 | EP1039898A1 Compositions comprising cannabinoids |
10/04/2000 | EP1039896A1 Method and composition for delivering zinc to the nasal membrane |
10/04/2000 | EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
10/04/2000 | EP1039890A1 Novel salts of metformin and method |
10/04/2000 | EP1039885A1 Use of c18 to c26 aliphatic alcohols for the manufacture of a medicament in the treatment of hyperproliferative skin disorders |
10/04/2000 | EP1039882A1 Therapeutic formulation for administering tolterodine with controlled release |
10/04/2000 | EP1039881A1 Composition for the controlled release of active compounds |
10/04/2000 | EP1039880A1 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
10/04/2000 | EP1039843A1 Biodegradable intra vaginal devices |
10/04/2000 | EP1039802A1 Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
10/04/2000 | EP0840595B1 Sunscreen compositions |
10/04/2000 | EP0821583B1 Dna vaccines against rotavirus infections |
10/04/2000 | EP0776228B1 Orally administrable delivery device |
10/04/2000 | EP0690719B1 Dry mix formulation for bisphosphonic acids |
10/04/2000 | EP0664705B1 Compositions of ergoline derivatives for the treatment of glaucoma |
10/04/2000 | EP0619731B1 Microcrystalline cellulose spheronization composition |
10/04/2000 | CN2399025Y External-use emplastrum |
10/04/2000 | CN1269013A Moleculars withch give out multiple active parts |
10/04/2000 | CN1268890A Sustained release tablet formulations to treat Parkinson disease |
10/04/2000 | CN1268888A Granule free of excipients |
10/04/2000 | CN1268885A Oral compositions |
10/04/2000 | CN1268869A Satiety product |
10/04/2000 | CN1268371A Preparation method of isotonic houttuynia injection |
10/04/2000 | CN1268370A Bifeigongxiening medicine for curing diseases of nasal hemorrhage, etc. |
10/04/2000 | CN1268367A Weichangyantong capsule for curing gastritis and enteritis and its production method |
10/04/2000 | CN1268366A Changtong inflammation relieving and pain-stopping oral liquor |
10/04/2000 | CN1268351A Female germicidal disinfectant contraceptive film |